Effects of somatostatin, a somatostatin agonist, and an antagonist, on a putative migraine trigger pathway

• Published in: Neuropeptides (Edinburgh) Vol. 103; p. 102399
• Main Authors: Lambert, Geoffrey A, Zagami, Alessandro S
• Format: Journal Article
• Language: English
• Published: Netherlands 01.02.2024
• Subjects: Animals; Headache; Migraine Disorders; Neurotransmitter Agents; Pain; Rats; Somatostatin - pharmacology; Cerebral cortex; Periaqueductal gray matter; Cortical spreading depression; Migraine; Flashing light; Nucleus raphe magnus; Triggers; Somatostatin; Trigeminal; Trigeminovascular
• ISSN: 0143-4179; 1532-2785
• DOI: 10.1016/j.npep.2023.102399

To determine whether somatostatin (SST) could be a cortico-brainstem neurotransmitter involved in producing the headache of migraine. There is evidence to support the idea that a cortico-brainstem-trigeminal nucleus neuraxis might be responsible for producing migraine headache; we have suggested that SST may be one of the neurotransmitters involved. Rats were anesthetised and prepared for recording neurons in either the periaqueductal gray matter (PAG) or nucleus raphe magnus (NRM), as well as the trigeminal nucleus caudalis (TNC). The dura mater and facial skin were stimulated electrically or mechanically. SST, the SST agonist L054264 and the SST antagonist CYN54806 were injected intravenously, by microinjection, or by iontophoresis into the PAG or NRM. Cortical neuronal activity was provoked by cortical spreading depression (CSD) or light flash (LF) and was monitored by recording cortical blood flow (CBF). Intravenous injection of SST: (a) selectively decreased the responses of TNC neurons to stimulation of the dura, but not skin, for up to 5 h; (b) decreased the ongoing discharge rate of TNC neurons while simultaneously increasing the discharge rate of neurons in either brainstem nucleus and; (c) prevented, or reversed, the effect of CSD and LF on brainstem and trigeminal neuron discharge rates. CSD and LF decreased the discharge rate of neurons in both brainstem nuclei and increased the discharge rate of TNC neurons. These effects were reversed by L054264 and mimicked by CYN54806. Injections of L054264 into the PAG or NRM reduced the response of TNC neurons to dural stimulation and skin stimulation differentially, depending on the nucleus injected. Injections of CYN54806 into either brainstem nucleus potentiated the responses of TNC neurons to dural and skin stimulation, but without a marked differential effect. These results imply that SST could be a neurotransmitter in a pathway responsible for migraine pain.